Table 1 |
||||
|
Citrullinated peptides in the ACPA microarray |
||||
|
Peptide |
Protein |
Amino acids |
Amino acid sequence |
Reference |
|
|
||||
|
CEP-1/Eno5-21 |
α-Enolase |
5-21 |
CKIHA(cit)EIFDS(cit)GNPTVEC (cyclic) |
[16] |
|
|
||||
|
Vim60-75 |
Vimentin |
60-75 |
VYAT(cit)SSAV(cit)L(cit)SSVP |
[37] |
|
|
||||
|
Vim2-17 |
Vimentin |
2-17 |
ST(cit)SVSSSSY(cit)(cit)MFGG |
[33] |
|
|
||||
|
CCP-1/Fil307-324 |
Filaggrin |
307-324 |
SHQEST(cit)GRSRGRSGRSGS (cyclic) |
|
|
|
||||
|
Fibβ36-52 |
Fibrinogen β-chain |
36-52 |
NEEGFFSA(cit)GHRPLDKK |
[37] |
|
|
||||
|
Fibβ563-583 |
Fibrinogen β-chain |
563-583 |
HHPGIAEFPS(cit)GKSSSYSKQF |
[13] |
|
|
||||
|
Fibβ580-600 |
Fibrinogen β-chain |
580-600 |
SKQFTSSTSYN(cit)GDSTFESKS |
c |
|
|
||||
|
Fibβ62-81aa |
Fibrinogen β-chain |
62-81 |
APPPISGGGY(cit)ARPAKAAAT |
[13] |
|
|
||||
|
Fibβ62-81bb |
Fibrinogen β-chain |
62-81 |
APPPISGGGYRA(cit)PAKAAAT |
[13] |
|
|
||||
|
Fibβ60-74 |
Fibrinogen β-chain |
60-74 |
(cit)PAPPPISGGGY(cit)A(cit) |
|
|
|
||||
|
Fibα621-635 |
Fibrinogen α-chain |
621-635 |
(cit)GHAKS(cit)PV(cit)GIHTS |
|
|
|
||||
|
citC1/CII359-369 |
Collagen type II |
359-369 |
(GPO)5-GA(cit)GLTG(cit)PGDA(GPO)2-GKKYG |
|
|
|
||||
|
The arginine-containing control peptides have identical sequences, except that they contain arginine residues instead of citrulline (Cit, citrulline). Peptides are designated by their abbreviated protein names (Eno, α-enolase; Vim, vimentin; Fib, fibrinogen; CII, type II collagen) followed by the positions of the first and last amino acid. For three peptides, earlier given specific names (CEP-1, CCP-1, citC1), these names are given in parallel. aCitrullinated at position 72. Uses the same control peptide containing two arginines as for Fibβ62-81b. bCitrullinated at position 74. Uses the same control peptide containing two arginines as for Fibβ62-81a. cThe citrullinated epitope in this peptide has been found to be citrullinated in RA synovial tissue (Per-Johan Jakobsson, personal communication). |
||||
|
Hansson et al. Arthritis Research & Therapy 2012 14:R201 doi:10.1186/ar4039 |
||||